Converting from Transdermal to Buccal Formulations of Buprenorphine: A Pharmacokinetic Meta-Model Simulation in Healthy Volunteers

Evaluation of the Pharmacokinetics of Single- and Multiple-dose Buprenorphine Buccal Film in Healthy Volunteers

(2016) Stephen A. Bai et al.   CLINICAL THERAPEUTICS

Treatment with subcutaneous and transdermal fentanyl: results from a population pharmacokinetic study in cancer patients

(2016) Astrid W. Oosten et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Dose-Dependent Flux of Buprenorphine Following Transdermal Administration in Healthy Subjects

(2016) Yi Wang et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Efficacy and tolerability of buccal buprenorphine in opioid-experienced patients with moderate to severe chronic low back pain

(2016) Joseph Gimbel et al.   PAIN

Buprenorphine Transdermal System for Opioid Therapy in Patients with Chronic Low Back Pain

(2016) Allan Gordon et al.   Pain Research & Management

Stochastic Pharmacokinetic–Pharmacodynamic Analysis of the Effect of Transdermal Buprenorphine on Electroencephalogram and Analgesia

(2015) Anne Estrup Olesen et al.   ANESTHESIA AND ANALGESIA

Effectiveness and Safety of Transdermal Buprenorphine Versus Sustained-release Tramadol in Patients With Moderate to Severe Musculoskeletal Pain

(2015) Xiaomei Leng et al.   CLINICAL JOURNAL OF PAIN

Efficacy and tolerability of buccal buprenorphine in opioid-naive patients with moderate to severe chronic low back pain

(2015) Richard L. Rauck et al.   POSTGRADUATE MEDICINE

The clinical analgesic efficacy of buprenorphine

(2014) R. B. Raffa et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Association of In Vivo κ-Opioid Receptor Availability and the Transdiagnostic Dimensional Expression of Trauma-Related Psychopathology

(2014) Robert H. Pietrzak et al.   JAMA Psychiatry

Pharmacokinetics of transdermal buprenorphine patch in the elderly

(2012) Nabil Al-Tawil et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Once-Weekly Transdermal Buprenorphine Application Results in Sustained and Consistent Steady-State Plasma Levels

(2012) Ram P. Kapil et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Efficacy and Safety of Buprenorphine Transdermal System (BTDS) for Chronic Moderate to Severe Low Back Pain: A Randomized, Double-Blind Study

(2011) Deborah Steiner et al.   JOURNAL OF PAIN

Efficacy and Safety of the Seven-Day Buprenorphine Transdermal System in Opioid-Naïve Patients with Moderate to Severe Chronic Low Back Pain: An Enriched, Randomized, Double-Blind, Placebo-Controlled Study

(2011) Deborah J. Steiner et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Pharmacokinetic/Pharmacodynamic Relationships of Transdermal Buprenorphine and Fentanyl in Experimental Human Pain Models

(2010) Trine Andresen et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Buprenorphine transdermal system in adults with chronic low back pain: A randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase

(2010) Allan Gordon et al.   CLINICAL THERAPEUTICS

A Randomized, Double-Blind, Double-Dummy Comparison of the Efficacy and Tolerability of Low-Dose Transdermal Buprenorphine (BuTrans® Seven-Day Patches) With Buprenorphine Sublingual Tablets (Temgesic®) in Patients With Osteoarthritis Pain

(2010) Ian G.V. James et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 μg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: A 12-week, randomized, open-label, controlled, parallel-group noninferiority study

(2009) Mats Karlsson et al.   CLINICAL THERAPEUTICS